Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. FDA has granted final approval of the Company’s Abbreviated New ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE